Strategic Inhibition of CHRM Autoantibodies: Molecular Insights and Therapeutic Potentials in Long COVID
Long COVID study finds autoantibodies attacking brain receptors disrupt cognition and cause sensory issues.
Targeted therapies like blood filtration show promise for relief.